Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial
Millie Long, Jessica R. Allegretti, Silvio Danese, Matthew Germinaro et autres
us, it, jp, fr (code pays fourni par la source)